134 related articles for article (PubMed ID: 27247112)
1. Identification of lesion subtypes in biopsies of ductal carcinoma in situ of the breast using biomarker ratio imaging microscopy.
Clark AJ; Petty HR
Sci Rep; 2016 Jun; 6():27039. PubMed ID: 27247112
[TBL] [Abstract][Full Text] [Related]
2. CDH2/N-cadherin and early diagnosis of invasion in patients with ductal carcinoma in situ.
Guvakova MA; Prabakaran I; Wu Z; Hoffman DI; Huang Y; Tchou J; Zhang PJ
Breast Cancer Res Treat; 2020 Sep; 183(2):333-346. PubMed ID: 32683564
[TBL] [Abstract][Full Text] [Related]
3. Availability of immunocytochemistry using cocktail antibody targeting p63/cytokeratin14 for the differential diagnosis of fibroadenoma and ductal carcinoma in situ in fine needle aspiration cytology of the breast.
Maeda I; Oana Y; Tsugawa K; Takagi M
Cytopathology; 2017 Oct; 28(5):378-384. PubMed ID: 28685877
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of CD44
Da Cruz Paula A; Leitão C; Marques O; Rosa AM; Santos AH; Rêma A; de Fátima Faria M; Rocha A; Costa JL; Lima M; Lopes C
Virchows Arch; 2017 Mar; 470(3):311-322. PubMed ID: 28116522
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
[TBL] [Abstract][Full Text] [Related]
6. An Uncommon Pairing of common Tumors: Case Report of Ductal Carcinoma
Marumoto A; Steinemann S; Furumoto N; Woodruff S
Hawaii J Med Public Health; 2019 Feb; 78(2):39-43. PubMed ID: 30766763
[TBL] [Abstract][Full Text] [Related]
7. Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.
Zhu J; Nie S; Wu J; Lubman DM
J Proteome Res; 2013 Jun; 12(6):2791-804. PubMed ID: 23679566
[TBL] [Abstract][Full Text] [Related]
8. The significance of extracellular mucin in breast fine needle aspiration specimens.
Shield PW; Ribu DL; Cominos D
Cytopathology; 2016 Jun; 27(3):185-92. PubMed ID: 26104545
[TBL] [Abstract][Full Text] [Related]
9. Preoperative diagnosis of ductal carcinoma in situ arising within a mammary fibroadenoma: a case report.
Ooe A; Takahara S; Sumiyoshi K; Yamamoto H; Shiba E; Kawai J
Jpn J Clin Oncol; 2011 Jul; 41(7):918-23. PubMed ID: 21693482
[TBL] [Abstract][Full Text] [Related]
10. Validation of an oligo-gene signature for the prognostic stratification of ductal carcinoma in situ (DCIS).
Geradts J; Groth J; Wu Y; Jin G
Breast Cancer Res Treat; 2016 Jun; 157(3):447-59. PubMed ID: 27250000
[TBL] [Abstract][Full Text] [Related]
11. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
Calaf GM; Ponce-Cusi R; Abarca-Quinones J
Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention.
Buckley N; Boyle D; McArt D; Irwin G; Harkin DP; Lioe T; McQuaid S; James JA; Maxwell P; Hamilton P; Mullan PB; Salto-Tellez M
Oncotarget; 2015 Dec; 6(41):43244-54. PubMed ID: 26657114
[TBL] [Abstract][Full Text] [Related]
13. Dynamic MR findings of ductal carcinoma in situ within a fibroadenoma.
Kato F; Omatsu T; Matsumura W; Takahashi M; Hosoda M; Takahashi H; Kubota K; Oyama-Manabe N; Terae S; Shirato H
Magn Reson Med Sci; 2011; 10(2):129-32. PubMed ID: 21720115
[TBL] [Abstract][Full Text] [Related]
14. Loss of FAT1 during the progression from DCIS to IDC and predict poor clinical outcome in breast cancer.
Wang L; Lyu S; Wang S; Shen H; Niu F; Liu X; Liu J; Niu Y
Exp Mol Pathol; 2016 Feb; 100(1):177-83. PubMed ID: 26721716
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.
Mardekian SK; Bombonati A; Palazzo JP
Hum Pathol; 2016 Mar; 49():114-23. PubMed ID: 26826418
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of CD205 in breast cancer: Simultaneous detection of myoepithelial cells and dendritic cells in breast tissue by CD205.
Ohe R; Aung NY; Tamura Y; Kabasawa T; Utsunomiya A; Tamazawa N; Kitaoka T; Meng HX; Shibata K; Yamakawa M
Histol Histopathol; 2020 May; 35(5):481-488. PubMed ID: 31524947
[TBL] [Abstract][Full Text] [Related]
17. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
El Sharkawy SL; Farrag AR
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.
Canas-Marques R; Schnitt SJ
Histopathology; 2016 Jan; 68(1):57-69. PubMed ID: 26768029
[TBL] [Abstract][Full Text] [Related]
19. CD74 interacts with CD44 and enhances tumorigenesis and metastasis via RHOA-mediated cofilin phosphorylation in human breast cancer cells.
Liu Z; Chu S; Yao S; Li Y; Fan S; Sun X; Su L; Liu X
Oncotarget; 2016 Oct; 7(42):68303-68313. PubMed ID: 27626171
[TBL] [Abstract][Full Text] [Related]
20. Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.
Lambein K; Van Bockstal M; Vandemaele L; Van den Broecke R; Cocquyt V; Geenen S; Denys H; Libbrecht L
Virchows Arch; 2017 Nov; 471(5):575-587. PubMed ID: 28567637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
